Pharmaceutical industry contribution to research is essential but full transparency and guidelines are required
- 29 August 2017
- journal article
- comment
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 32 (10), 2147-2148
- https://doi.org/10.1093/humrep/dex282
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public healthHuman Reproduction, 2017
- Gynaecologists and industry: ain't no sunshineHuman Reproduction, 2017
- How much do clinical trials cost?Nature Reviews Drug Discovery, 2017
- Key cost drivers of pharmaceutical clinical trials in the United StatesClinical Trials, 2016
- Investigator initiated trials (IITs)Perspectives in Clinical Research, 2012